Search

Your search keyword '"Ducrocq G"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Ducrocq G" Remove constraint Author: "Ducrocq G" Topic acute coronary syndrome Remove constraint Topic: acute coronary syndrome
24 results on '"Ducrocq G"'

Search Results

1. Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome.

2. Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.

3. Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO Trial.

4. Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insights from the TAO randomized clinical trial.

5. Chest pain triage: do genetics have a role?

6. Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.

7. Timing of Angiography and Outcomes in High-Risk Patients With Non-ST-Segment-Elevation Myocardial Infarction Managed Invasively: Insights From the TAO Trial (Treatment of Acute Coronary Syndrome With Otamixaban).

8. Early diagnosis of acute coronary syndrome.

9. Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes.

10. Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial.

11. Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome).

12. Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.

13. Recurrent acute coronary syndromes are associated with increased shear induced platelet aggregation. A case-control study.

14. Slow response to clopidogrel predicts low response.

15. Prevalence of embolic signals in acute coronary syndromes.

16. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.

17. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

18. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

19. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

20. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

21. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

22. Le coronarien âgé : un patient à haut risque hémorragique.

23. Comparaison des recommandations européennes (ESC) et américaines (ACC/AHA) concernant la prise en charge initiale des syndromes coronariens aigus avec sus décalage du segment ST.

24. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Catalog

Books, media, physical & digital resources